COURT-RULING ·Filed Mar 30, 2026
Court ruling (district)
Actionable Insight • Neutral
Monitor for subsequent filings in this case, including motions to dismiss or responsive pleadings, which may clarify the nature and potential exposure of the litigation. Given the lack of accessible ruling details, no immediate trading action is warranted.
Final — all horizons settled through T+60d
CLLS ▼ -6.77% at T+60d
NEUTRAL call -6.77% · α vs SPY -23.27% · entry $3.10 → $2.89
T+1d
+2.26%
call +2.26% · α -0.63%
$3.17
settled 7mo ago
T+5d
+8.39%
call +8.39% · α +4.09%
$3.36
settled 7mo ago
T+20d
+29.03%
call +29.03% · α +16.44%
$4.00
settled 6mo ago
T+60d
-6.77%
call -6.77% · α -23.27%
$2.89
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable
Court Ruling Details
Court
United States District Court for the District of Delaware
Court Level
District
Case Type
other
Ruling Type
other
Outcome
PARTIAL — mixed ruling, some claims won/lost
Precedent Risk
LOW
Key Facts
- Case: Factor Bioscience Inc. v. Cellectis, Inc. et al (1:25-cv-01197) filed in U.S. District Court for the District of Delaware
- Filed on 2026-03-30, status unknown
- Matched company: Cellectis S.A. (CLLS), involved as defendant
Financial Impact
Unknown — no financial details available from ruling text
Risk Factors
- Potential undisclosed material litigation risk if claim involves core IP or commercial operations
- Risk of future adverse ruling if complaint alleges significant damages or injunctive relief
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-2fvkkbxt-CLLS |
14 reports for CLLS
40% Hit rate @ T+60 Went positive at some point 4 of 6 best @ T+20▲ +35.52%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 6w ago | 6-K | $1.83 | awaiting T+60 | — | $0.9670 (+47.16%) |
Sep 11, 2026 6w ago | Press Release | $1.83 | awaiting T+60 | — | $0.9670 (−47.16%) |
Aug 6, 2026 11w ago | Press Release | $2.84 | awaiting T+60 | — | $0.9670 (−65.89%) |
Jun 29, 2026 17w ago | Court Ruling | $3.00 $1.43 | ▼ −52.33% | ▼ −55.32% | $0.9670 (−67.77%) |
Jun 25, 2026 17w ago | 6-K | $2.83 $1.51 | ▼ −46.64% | ▼ −52.75% | $0.9670 (−65.83%) |
Jun 25, 2026 17w ago | 6-K | $2.83 $1.51 | ▼ −46.64% | ▼ −52.75% | $0.9670 (−65.83%) |
Jun 11, 2026 19w ago | Press Release | $3.09 $3.24 | ▲ +4.85% | ▲ +0.46% | $0.9670 (−68.71%) |
Jun 9, 2026 19w ago | 6-K | $3.18 $3.32 | ▲ +4.40% | ▼ −2.18% | $0.9670 (−69.59%) |
May 12, 2026 23w ago | 6-K | $3.96 $2.69 | ▼ −32.07% | ▼ −36.45% | $0.9670 (−75.58%) |
May 4, 2026 25w ago | 6-K | $3.76 $2.85 | ▼ −24.20% | ▼ −26.94% | $0.9670 (−74.28%) |
Showing 10 of 14
US Market Status
Market Closed — Opens in 3h 56m
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers